Nickel(II) acetylacetonate
Product Information
Molecular Formula
Ni(C5H7O2)2
Molecular Weight
256.91
Description
Nickel(II) acetylacetonate is a well-known biomedical compound that showcases its vivid therapeutic potential against a plethora of pathological anomalies, spanning from malignant neoplasms to intricate neurologic maladies. Its formidable capability operates through arresting the tumultuous proliferation and expansion of malignant cells, thereby instigating a compelling defense mechanism against cancer. Moreover, its commendable neuroprotective traits have augmented its significance in effectively combating neurodegenerative dysfunctions, heralding a groundbreaking breakthrough in the domain of medical science.
Synonyms
2,4-Pentanedione nickel(II) derivative,Ni(acac)2
IUPAC Name
nickel(2+)(Z)-4-oxopent-2-en-2-olate
SMILES
CC(=O)\C=C(\C)O[Ni]O\C(C)=C/C(C)=O
InChI
InChI=1S/2C5H8O2.Ni/c2*1-4(6)3-5(2)7/h2*3,6H,1-2H3/q+2/p-2/b2*4-3-
InChI Key
BMGNSKKZFQMGDH-FDGPNNRMSA-L
Melting Point
230 °C (dec.) (lit.)
Flash Point
Not applicable
Purity
95%
Application
Used as a catalyst; Used in organic synthesis to produce organometals and as a catalyst.
Safety Information
Hazards
H302 - H317 - H350
Precautionary Statement
P201 - P280 - P301 + P312 + P330 - P308 + P313
Signal Word
Danger
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
256.024551 g/mol
Monoisotopic Mass
256.024551 g/mol
Topological Polar Surface Area
80.3Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
90.4
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
2
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
3
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2020181104-A1 | Ssao inhibitors and uses thereof | 2018-10-24 |
| WO-2020086747-A2 | Ssao inhibitors and uses thereof | 2018-10-24 |
| AU-2019365213-A1 | SSAO inhibitors and uses thereof | 2018-10-24 |
| EP-3870162-A2 | Ssao inhibitors and uses thereof | 2018-10-24 |
| JP-2022504697-A | SSAO inhibitors and their use | 2018-10-24 |
| US-2022002309-A1 | Ssao inhibitors and uses thereof | 2018-10-24 |
| US-2013202538-A1 | Molecular Switch | 2010-08-16 |
| US-2013116113-A1 | Catalyst composition, production process for norbornene base copolymer by using catalyst composition, norbornene base copolymer and heat resistant film prepared by using the same | 2010-07-28 |
| CA-1086331-A | Substituted benzopinacols and their preparation | 1977-05-23 |
| DE-2822541-A1 | BENZOPINACOLE AND METHOD OF MANUFACTURING BENZOPINACOLEN | 1977-05-23 |
